Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
Search for other papers by Wilmar M. Wiersinga in
Google Scholar
PubMed
evaluation [ 8 ]. The FDA distinguishes between clinician-reported outcomes (CRO) based on clinical observation and interpretation by a trained clinician, and patient-reported outcomes (PRO) based on a report that comes directly from the patient about the
Centre for Exercise, Nutrition and Health Sciences, School for Policy Studies, University of Bristol, Bristol, United Kingdom
Search for other papers by Clare Yvonne England in
Google Scholar
PubMed
Search for other papers by Laura Moss in
Google Scholar
PubMed
Search for other papers by Matthew Beasley in
Google Scholar
PubMed
Search for other papers by Ingrid Haupt-Schott in
Google Scholar
PubMed
Search for other papers by Georgia Herbert in
Google Scholar
PubMed
Search for other papers by Charlotte Atkinson in
Google Scholar
PubMed
%) reported using the UK LID-WG diet sheet. Of those who did not, 4 (9%) were not aware of the working group suggestions and clinicians from 4 centres (9%) thought it was too restrictive; one of them specifically said they did not advise people to restrict
Search for other papers by Radu Mihai in
Google Scholar
PubMed
contrast with the relatively low figures quoted by clinicians, an international survey of over 2300 patients with thyroid cancer organised by the Thyroid Cancer Alliance showed that 36% of patients experienced unfavourable voice outcomes ( 6 ). Very similar
Search for other papers by Alice Nervo in
Google Scholar
PubMed
Search for other papers by Alberto Ragni in
Google Scholar
PubMed
Search for other papers by Alessandro Piovesan in
Google Scholar
PubMed
Search for other papers by Valentina Marica in
Google Scholar
PubMed
Search for other papers by Enrica Migliore in
Google Scholar
PubMed
Search for other papers by Marco Gallo in
Google Scholar
PubMed
Search for other papers by Emanuela Arvat in
Google Scholar
PubMed
adequately assessed. The Patient-Reported Outcomes version of the CTCAE (PRO-CTCAE) was conceived with the aim of capturing symptomatic toxicities directly by the patient in order to minimise biases [ 10 ]. Ideally, it should allow detecting AEs at an earlier
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Hospital de Braga, Braga, Portugal
Search for other papers by Maria Lopes-Pereira in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Anna Quialheiro in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Patrício Costa in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Susana Roque in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
ACMP5 – Associação Centro de Medicina P5 (P5), School of Medicine, University of Minho, Braga, Portugal
Search for other papers by Nadine Correia Santos in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Margarida Correia-Neves in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Search for other papers by Ana Goios in
Google Scholar
PubMed
Search for other papers by Ivone Carvalho in
Google Scholar
PubMed
Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands
The Generation R Study Group, Erasmus MC, University Medical Center, Rotterdam, the Netherlands
Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed
Search for other papers by Laura Vilarinho in
Google Scholar
PubMed
ICVS/3B’s, PT Government Associate Laboratory, Braga/Guimarães, Portugal
Clinical Academic Center-Braga (2CA-B), Braga, Portugal
Search for other papers by Joana Almeida Palha in
Google Scholar
PubMed
iodine supplementation recommendation has been fulfilled and whether the reported use of iodine supplements was associated with obstetrics and neonatal outcomes. Materials and methods Study design and population This observational
Search for other papers by Salman Razvi in
Google Scholar
PubMed
Search for other papers by Bronia Arnott in
Google Scholar
PubMed
Search for other papers by Dawn Teare in
Google Scholar
PubMed
Search for other papers by Shaun Hiu in
Google Scholar
PubMed
Search for other papers by Nicki O’Brien in
Google Scholar
PubMed
Search for other papers by Simon H. Pearce in
Google Scholar
PubMed
thyroid healthcare professional organisations are being followed with regard to the management of SCH in older individuals. We therefore conducted a multinational survey of clinicians interested in the management of thyroid disease. Methods
Search for other papers by Alex Stagnaro-Green in
Google Scholar
PubMed
that the woman was euthyroid prior to conception. Estimates are that 2-3% of all pregnant women have undiagnosed SCH, with some recent studies reporting a prevalence rate of over 10%. Another subset of women prone to develop SCH are individuals who were
Search for other papers by Sofie Larsen Rasmussen in
Google Scholar
PubMed
Search for other papers by Lars Rejnmark in
Google Scholar
PubMed
Search for other papers by Eva Ebbehøj in
Google Scholar
PubMed
Search for other papers by Ulla Feldt-Rasmussen in
Google Scholar
PubMed
Search for other papers by Åse Krogh Rasmussen in
Google Scholar
PubMed
Search for other papers by Jakob Bue Bjorner in
Google Scholar
PubMed
Search for other papers by Torquil Watt in
Google Scholar
PubMed
ambiguous data as well as the time-consuming effort of manual typing [ 2 ]. Electronic data collection can be made accessible through the Internet, and might thus be more convenient for the respondent [ 3 ]. ThyPRO is a patient-reported outcomes
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
-quality POU report provides more pertinent information, enabling clinicians to more reliably estimate RTT and future RR. Given the limited number of FNAs and additional surgeries performed for abnormal lesions in our cohorts, particularly those following POU
Search for other papers by Samuel Chan in
Google Scholar
PubMed
Search for other papers by Katarina Karamali in
Google Scholar
PubMed
Search for other papers by Anna Kolodziejczyk in
Google Scholar
PubMed
Search for other papers by Georgios Oikonomou in
Google Scholar
PubMed
Search for other papers by John Watkinson in
Google Scholar
PubMed
Search for other papers by Vinidh Paleri in
Google Scholar
PubMed
Search for other papers by Iain Nixon in
Google Scholar
PubMed
Search for other papers by Dae Kim in
Google Scholar
PubMed
the widely accepted recurrence rate of 1–3% in low-risk DTC [ 3 ]. More concerning, however, is the wide variability in reported recurrence rates after HT, with 2 studies by Shaha et al. [ 22 ] and Hay et al. [ 23 ], both examining outcomes in low